AI-generated summary
This Cochrane systematic review pooled three randomised controlled trials of intense pulsed light for meibomian gland dysfunction, enrolling 114 adults. The authors report little to no reduction in dry eye symptoms compared with sham treatment, and that evidence on tear break-up time and tear osmolarity was low certainty, so effectiveness and safety remain uncertain.
- Participants
- 114
- Studies included
- 3
- Who or what was studied
- Adults with meibomian gland dysfunction and dry eye disease
- Limits stated in the abstract
- Only three small trials were included, none at low risk of bias in all domains, evidence was mostly very low certainty, and adverse events were poorly reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Sham, Risk of bias, Randomized controlled trial, Confidence interval, Systematic review, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.